Primary adrenal failure and hypothyroidism adverse effect with nivolumab immuno‐oncology agent. JEMDSA Vol 23(3) 2019 Supp S144-145

GÜNEŞ E., CANDER S., ÖZ GÜL Ö., ERSOY C.

18th International Congress of Endocrinology, 53rd Society for Endocrinology, Metabolism and Diabetes of South Africa (SEMDSA) Congress, 1 - 04 Aralık 2018

  • Yayın Türü: Bildiri / Tam Metin Bildiri
  • Bursa Uludağ Üniversitesi Adresli: Evet